ERBB2 and breast carcinoma: In breast cancer, HER2 mutations occur in 3% of cases, most commonly in exon 19, with mutations in the L755 allele encoding the intracellular domain of tyrosine being the most common, accounting for 22% of mutations (Xu et al., 2017).